Stopped: COVID-19 pandemic and lack of funding necessary for continuation
This collaborative study in 9 geriatrics units across Europe aims to apply emerging research to clinical practice, following the "Action-Research Philosophy" (11). The overall goal is to improve care in patients with - and help prevent - sarcopenia. Understanding the frequency of and risk factors for developing sarcopenia in an acute hospital setting, may help shed light on potential interventions and thus inform the development of future therapeutic strategies. It involves crucial implications for research, clinical practice, and policy towards optimal aging.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of sarcopenia as defined by the European consensus on definition and diagnosis (EWGSOP2)
Timeframe: One year (March 2019-March 2020)
Incidence of sarcopenia as defined by the European consensus on definition and diagnosis (EWGSOP2)
Timeframe: One year (March 2019-March 2020)